Home / Inspections / 1279864

FDA Inspection 1279864 — Frontida BioPharm Inc

Frontida BioPharm Inc — FEI 2523348

The FDA completed an inspection of Frontida BioPharm Inc on July 22, 2025 in Philadelphia, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Tobacco.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 22, 2025
Fiscal Year
2025
Product Type
Tobacco
Project Area
Tobacco Post-Market Activities
Location
Philadelphia, PA (United States)

Facility

Other inspections at this facility

  • 1316756 (NAI Thu Apr 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1226606 (VAI Thu Dec 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1097023 (VAI Fri Jul 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1007832 (VAI Fri Mar 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 936055 (OAI Fri Jul 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources